We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Teva Announces FDA Acceptance of NDA for SD-809 for Huntington Disease Treatment

News   Aug 17, 2015

 
Teva Announces FDA Acceptance of NDA for SD-809 for Huntington Disease Treatment
 
 
 

RELATED ARTICLES

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

New Insights Could Change How Concussions Are Treated

News

New research questions the ongoing hypothesis that the blunt force behind a traumatic brain injury (TBI) causes nerve damage, or axonal injury. The findings could influence the treatment of and development of new drugs for TBI.

READ MORE

“Sticky” Gene Could Help Valium Calm Nerves

News

Scientists have discovered that Valium and other benzodiazepines may need the assistance of a "sticky" gene, named after a mythological figure, called Shisa7, to "calm" nerves.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE